Not_yet_recruitingNANCT07214506

Human Papillomavirus Self-Sampling Options to Promote Equity (HOPE)

Sponsor: University of Arizona

Trial Details

Condition	Uterine Cervical Neoplasms, HPV Testing, Pap Smear
Intervention	Human papillomavirus Self-collection; Usual Care
Phase	NA
Status	Not_yet_recruiting
Participants	100
Est. Completion	31 Dec 2026
Last Updated	29 May 2026

Primary Outcome

Cervical Cancer Screening Completion

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Women or transgender men with a cervix * Ages 30-64 years * Due for cervical cancer screening: 1. No Pap test in the past 3 years, or 2. No human papillomavirus (HPV) test in the past 5 years * Unhoused or unstably housed Exclusion Criteria: * History of cervical cancer * HIV positive * History of total hysterectomy * Known pregnancy

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

HOPE Trial: Mobile HPV Self-Sampling for Unhoused Women — Addressing Cervical Cancer Screening Inequities

The HOPE trial investigates mobile HPV self-sampling to improve cervical cancer screening among unhoused women in Arizona. This community-based approach could transform preventive care access for vulnerable populations.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service